feed,title,long_url,short_url
SeekingAlpha,Crown Laboratories to buy Revance Therapeutics for $6.66/share in cash,https://seekingalpha.com/news/4138589,
SeekingAlpha,PAR upgraded after transition to pure-play restaurant provider: Jefferies,https://seekingalpha.com/news/4138566,
SeekingAlpha,Kopin regains compliance with Nasdaq minimum bid price requirement,https://seekingalpha.com/news/4138588,
SeekingAlpha,"Datadog, MongoDB, Snowflake in spotlight as cloud consumption rose in July: BofA",https://seekingalpha.com/news/4138587,
